Emerging drugs for treating the acute respiratory distress syndrome. (2019)
Attributed to:
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/14728214.2019.1591369
PubMed Identifier: 30841764
Publication URI: http://europepmc.org/abstract/MED/30841764
Type: Journal Article/Review
Volume: 24
Parent Publication: Expert opinion on emerging drugs
Issue: 1
ISSN: 1472-8214